Genetic Deafness

FDA grants accelerated approval for first gene therapy targeting genetic deafness

Regeneron’s Otarmeni marks the first neurosensory gene therapy to reach the market, yet its rapid path through the FDA raises questions about long-term efficacy and the high cost … Apr 24, 2026

Science

'Deafness reversed': Karolinska-led trial restores hearing in 10 people — but there are big caveats

A single injection of AAV gene therapy delivered a working OTOF gene and improved hearing in ten patients within weeks, researchers report. The results are striking for one rare f… Apr 05, 2026

Genetics

Lilly’s $1.1B Recombinase Push for Hearing Loss

Eli Lilly has inked an exclusive research and licensing deal with Seamless Therapeutics worth up to $1.12 billion to develop programmable recombinase gene-editing therapies for in… Jan 28, 2026

Science

Viagra-like Drug Restores Hearing in Genetic Models

A new study links rare CPD gene mutations to congenital hearing loss and shows that restoring arginine–nitric oxide signaling — with supplements or sildenafil — rescues auditory c… Nov 18, 2025

Articles about Genetic Deafness

FDA grants accelerated approval for first gene therapy targeting genetic deafness

'Deafness reversed': Karolinska-led trial restores hearing in 10 people — but there are big caveats

Lilly’s $1.1B Recombinase Push for Hearing Loss

Viagra-like Drug Restores Hearing in Genetic Models